Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F0YA3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,987
Award facts
- Contract value 100% obligated
- $14,987.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $14,987.28 on December 10, 2025, for the supply of Enhertu 100 mg vials, with completion expected by January 2, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
Enhertu is a specialized oncology medication used in cancer treatment, reflecting the breadth of pharmaceutical products delivered through AmerisourceBergen's federal contracts. The company maintains a significant role in supporting Defense Health Agency medical supply chains, providing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen demonstrates consistent capability to fulfill federal procurement requirements through competitive processes and maintains the operational capacity to support military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F0YA3?
SPE2DR26F0YA3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F0YA3 worth?
The government has obligated $14,987 on SPE2DR26F0YA3.
Is contract SPE2DR26F0YA3 an order under another contract?
Yes. SPE2DR26F0YA3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YA3 competed?
The extent of competition for SPE2DR26F0YA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award